BRPI0906754A2 - Formulário de dosage prolongado da libertação de paliperidone - Google Patents

Formulário de dosage prolongado da libertação de paliperidone

Info

Publication number: BRPI0906754A2
Authority: BR; Brazil
Prior art keywords: dosage form; release extended; extended dosage; paliperidone; paliperidone release
Prior art date: 2008-02-04

Application number

BRPI0906754-0A

Other languages

English (en)

Inventor

Ganesan Murugesan

Jaya Abraham

Vinodkumar Gupta

Bhavesh Shah

Original Assignee

Torrent Pharmaceuticals Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-02-04

Filing date

2009-02-03

Publication date

2015-07-07

2009-02-03 Application filed by Torrent Pharmaceuticals Ltd filed Critical Torrent Pharmaceuticals Ltd

2015-07-07 Publication of BRPI0906754A2 publication Critical patent/BRPI0906754A2/pt

Links

PMXMIIMHBWHSKN-UHFFFAOYSA-N 3-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl}-9-hydroxy-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one Chemical compound FC1=CC=C2C(C3CCN(CC3)CCC=3C(=O)N4CCCC(O)C4=NC=3C)=NOC2=C1 PMXMIIMHBWHSKN-UHFFFAOYSA-N 0.000 title 1
239000002552 dosage form Substances 0.000 title 1
229960001057 paliperidone Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone

Landscapes

Health & Medical Sciences (AREA)
Epidemiology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

BRPI0906754-0A 2008-02-04 2009-02-03 Formulário de dosage prolongado da libertação de paliperidone BRPI0906754A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IN232MU2008		2008-02-04
PCT/IN2009/000072 WO2009109993A1 (en)	2008-02-04	2009-02-03	Extended release dosage form of paliperidone

Publications (1)

Publication Number	Publication Date
BRPI0906754A2 true BRPI0906754A2 (pt)	2015-07-07

Family

ID=40933755

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0906754-0A BRPI0906754A2 (pt)	2008-02-04	2009-02-03	Formulário de dosage prolongado da libertação de paliperidone

Country Status (3)

Country	Link
US (1)	US20110027361A1 (pt)
BR (1)	BRPI0906754A2 (pt)
WO (1)	WO2009109993A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2326312A1 (en) *	2008-07-25	2011-06-01	KRKA, D.D., Novo Mesto	Paliperidone composition comprising solid matrix particles
EP2161019A1 (en) *	2008-09-05	2010-03-10	KRKA, D.D., Novo Mesto	Prolonged release multiparticulate pharmaceutical composition comprising paliperidone
WO2011018246A2 (en) *	2009-08-13	2011-02-17	Synthon B.V.	Controlled release paliperidone composition
WO2011045774A2 (en) *	2009-10-16	2011-04-21	Ranbaxy Laboratories Limited	Extended release pharmaceutical compositions of paliperidone and processes of preparation thereof
CN102106807B (zh) *	2009-12-29	2013-03-27	上海中西制药有限公司	一种固体制剂的制备方法及所得固体制剂
EP2547206B1 (en) *	2010-03-15	2016-05-11	Inventia Healthcare Private Limited	Stabilized prolonged release pharmaceutical composition comprising atypical antipsychotic
CN102058517A (zh) *	2010-12-31	2011-05-18	泰州万全医药科技有限公司	一种帕潘立酮缓释剂及其制备方法
WO2015120110A2 (en) *	2014-02-07	2015-08-13	Auspex Pharmaceuticals, Inc.	Novel pharmaceutical formulations
US9844551B2 (en)	2015-01-14	2017-12-19	Children's Hospital Medical Center	Compositions and methods for treatment of fragile X syndrome
GR1008842B (el) *	2015-08-06	2016-09-05	Φαρματεν Ανωνυμος Βιομηχανικη Και Εμπορικη Εταιρεια Φαρμακευτικων Ιατρικων Και Καλλυντικων Προϊοντων	Φαρμακευτικο σκευασμα περιεχον εναν ατυπο αντιψυχωσιμο παραγοντα και μεθοδος για την παρασκευη αυτου
MA42799A (fr) *	2015-12-29	2018-07-25	Sanovel Ilac Sanayi Ve Ticaret As	Mini comprimés de palipéridone
WO2018098115A1 (en) *	2016-11-23	2018-05-31	Children's Hospital Medical Center	Paliperidone for treatment of drug refractory irritability and autism spectrum disorder
CA3244297A1 (en) *	2021-12-29	2023-07-06	Jrs Pharma Gmbh & Co. Kg	LUBRICANT FOR PHARMACEUTICAL AND NUTRACEUTIC PRODUCTS
CN114983960B (zh) *	2021-12-29	2024-01-30	微研优仿医药科技(江苏)有限公司	一种药物组合物及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5792477A (en) *	1996-05-07	1998-08-11	Alkermes Controlled Therapeutics, Inc. Ii	Preparation of extended shelf-life biodegradable, biocompatible microparticles containing a biologically active agent
JP2008509144A (ja) *	2004-08-04	2008-03-27	アルザ・コーポレーシヨン	上昇するゼロ次放出パターンを示す持続薬剤放出組成物、そのような組成物を製造する方法
PL2079446T3 (pl) *	2007-08-21	2012-04-30	Teva Pharma	Preparat paliperidonu o przedłużonym uwalnianiu
WO2009026621A1 (en) *	2007-08-29	2009-03-05	Alphapharm Pty Ltd	Pharmaceutical compound & composition

2009
- 2009-02-03 US US12/865,801 patent/US20110027361A1/en not_active Abandoned
- 2009-02-03 BR BRPI0906754-0A patent/BRPI0906754A2/pt not_active IP Right Cessation
- 2009-02-03 WO PCT/IN2009/000072 patent/WO2009109993A1/en not_active Ceased

Also Published As

Publication number	Publication date
WO2009109993A1 (en)	2009-09-11
US20110027361A1 (en)	2011-02-03

Legal Events

Date	Code	Title	Description
2015-12-01	B08F	Application fees: application dismissed [chapter 8.6 patent gazette]	Free format text: REFERENTE AS 4A, 5A E 6A ANUIDADES.
2016-04-05	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

Publication	Publication Date	Title
BRPI0906754A2 (pt)	2015-07-07	Formulário de dosage prolongado da libertação de paliperidone
DK3097925T3 (da)	2019-08-05	Farmaceutisk sammensætning
BRPI0920521A2 (pt)	2018-01-16	combinação farmacêutica
BRPI1004940A2 (pt)	2018-06-19	composição farmacêutica
EP2240022A4 (en)	2012-04-25	PHARMACEUTICAL COMPOSITIONS
EP2419097A4 (en)	2012-09-05	PHARMACEUTICAL COMPOSITIONS
EP2451274A4 (en)	2014-04-02	Pharmaceutical compositions
ATE518527T1 (de)	2011-08-15	Rasagilinformulierung mit verzögerter freisetzung
SMT201700095B (is)	2017-03-08	Composizioni farmaceutiche per inalazione
DK2376490T3 (da)	2013-04-15	Imidazopyridinforbindelser
SMT201400069B (it)	2014-07-07	Formulazione farmaceutica
EP2373681A4 (en)	2013-11-06	PHARMACEUTICAL COMPOSITIONS
BRPI1015939A2 (pt)	2016-09-27	composição farmacêutica
BRPI0908114A2 (pt)	2015-10-06	tabuleta oral de liberação controlada
DK2391349T3 (da)	2014-11-03	Farmaceutisk sammensætning omfattende 2-oco-1-pyrrolidin-derivater
BRPI1009465A2 (pt)	2015-08-18	Formulação
DK2285413T3 (da)	2012-08-27	Farmaceutisk sammensætning
EP2236149A4 (en)	2012-12-26	MEDICAL COMPOSITION
BRPI0921654A2 (pt)	2016-02-10	formulação farmacêutica
DK2391351T3 (da)	2014-12-01	Farmaceutisk sammensætning omfattende 2-oxo-1-pyrrolidinderivater
IT1394400B1 (it)	2012-06-15	Composizioni farmaceutiche
FI20086158A0 (fi)	2008-12-03	Imidatsopyridiinijohdannaiset
EP2460415A4 (en)	2014-02-19	COATED PREPARATION
BRPI0921313A2 (pt)	2015-12-29	composição farmaucêutica
BRPI0912428A2 (pt)	2016-02-16	formulação farmacêutica sólida de liberação retardada